Cancer Health Fall Issue

The trial will soon have nearly 40 study arms testing different targeted therapies.

Waiting more than 30 days after surgery was associated with worse outcomes.

In tumors with missing or mutated BRCA genes, PARP inhibitors plus other drugs have worked well—but the cancer often becomes drug-resistant.

Imbruvica-based treatment may also work better than intensive chemotherapy for younger patients.

“There isn’t necessarily a pressure to innovate unless doctors listen to patients.”

Drug prevents mental decline associated with radiation therapy in mice.

A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco

An estimated 10 percent of people who access their records online end up requesting corrections—for a variety of reasons.

ASH 2018 conference highlights precision medicine, machine learning and gut microbiome.